1. |
Bodis-Wollner I. Retinopathy in Parkinson's disease[J]. J Neural Transm, 2009, 116:1493-1501.
|
2. |
Altintas O, Iseri P, Ozkan B, et al. Correlation between retinal morphological and functional findings and clinical severity in Parkinson's disease[J]. Doc Ophthalmol, 2008, 1116:137-146.
|
3. |
Hajee ME, March WF, Lazzaro DR, et al. Inner retinal layer thinning in Parkinson disease[J]. Arch Ophthalmol, 2009, 127:737-741.
|
4. |
Fahn S, Marsden CD, Calne DB, et al. Recent developments in Parkinson's Disease[M]. Puerto Rico:Raven Pr, 1987:293-304.
|
5. |
Reichmann H. Clinical criteria for the diagnosis of Parkinson's disease[J].Neurodegener Dis, 2010, 7:284-290.
|
6. |
Harwerth RS, Quigley HA.Visual field defects and retinal ganglion cell losses in patients with glaucoma[J].Arch Ophthalmol, 2006, 124:853-859.
|
7. |
Yenice O, Onal S, Midi I, et al. Visual field analysis in patients with Parkinson's disease[J]. Parkinsonism Relat Disord, 2008, 14:193-198.
|
8. |
Archibald NK, Clarke MP, Mosimann UP, et al. The retina in Parkinson's disease[J]. Brain, 2009, 132:1128-1145.
|
9. |
Inzelberg R, Ramirez JA, Nisipeanu P, et al. Retinal nerve fiber layer thinning in Parkinson disease[J]. Vision Res, 2004, 44:2793-2797.
|
10. |
Altintas O, Iseri P, Ozkan B, et al. Correlation between retinal morphological and functional findings and clinical severity in Parkinsons disease[J]. Doc Ophthalmol, 2008, 1116:137-146.
|
11. |
赵颖, 戴惟葭.早期帕金森病患者视网膜神经纤维层厚度变化与视野平均缺损的关系[J].中华眼底病杂志, 2010, 26:339-342.
|
12. |
Quigley HA, Dunkelberger GR, Green WR. Retinal ganglion cell atrophy correlated with automated permietry in human eyeswith glaucoma[J].Am J Ophthalmol, 1989, 107:453-464.
|
13. |
Yavas GF, Yilmaz O, Küsbeci T, et al. The effect of levodopa and dopamineagonists on optic nerve head in Parkinson's disease. Eur J Ophthalmol, 2007, 17:812-816.
|
14. |
La Morgia C, Barboni P, Rizzo G, et al. Loss of temporal retinal nerve fibers in Parkinson's disease:a mitochondrial pattern[J]. Eur J Neurol, 2013, 20:198-201.
|
15. |
Harwerth RS, Quigley HA.Visual field defects and retinal ganglion cell losses in patients with glaucoma[J].Arch Ophthalmol, 2006, 124:853-859.
|
16. |
Gazzard G, FosterPJ, Devereux JG, et al. Intraocular pressure and visual field loss in primary angle closure and primary open angle glaucomas[J]. Br J Ophthalmol, 2003, 87:720-725.
|
17. |
Cubo E, Tedejo RP, Rodriguez Mendez V, et al. Retina thickness in Parkinson'sdisease and essential tremor[J]. Mov Disord, 2010, 25:2461-2477.
|
18. |
Sugiyama T, Utsunomiya K, Ota H, et al. Comparative study of cerebral blood flow in patients with normal-tension glaucoma and control subjects[J].Am J Ophthalmol, 2006, 141:394-396.
|
19. |
Yang H, Zhou HY, Li B, et al. Neuroprotection of Parkin against apoptosis is independent of inclusion body formation[J]. Neuroreport, 2005, 16:1117-1121.
|
20. |
Andreas U, Othmar N, Francis F, et al. Association of glaucoma with neurodegenerative diseases with apoptotic cell death:Alzheimer's disease and Parkinson's disease[J]. Am J Ophthalmol, 2002, 133:135-137.
|